Despite the reduced representation in the liver, the percentage of CD3+CD56+ cells in PBMCs was comparable between HCC patients and healthy donors (Fig. 1c), indicating that it is likely the consequence of altered local microenvironment rather than a systemic effect. The gene discussed is NCAM1; the disease is hepatocellular carcinoma.